Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis
Martina Korfei(Justus-Liebig-Universität Gießen), Andreas Günther(Cardio-Pulmonary Institute)
Cited by 57
Related Papers
Phenotypes of organ involvement in sarcoidosis
|European Respiratory Journal|2018|245
Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27
|Proceedings of the National Academy of Sciences|2023|31
Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cells
|Journal of Cystic Fibrosis|2020|18
Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment
|Nature Communications|2025|13
A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease
|American Journal of Respiratory and Critical Care Medicine|2026|1